INVITRO AND INVIVO EVALUATION OF 7 50 MG AND 100 MG NITROFURANTOIN TABLETS

被引：3

作者：

MEYER, MC

WOOD, GC

STRAUGHN, AB

机构：

来源：

BIOPHARMACEUTICS & DRUG DISPOSITION | 1989年 / 10卷 / 03期

关键词：

D O I：

10.1002/bdd.2510100310

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：321 / 329

页数：9

共 19 条

[1]

AUFRERE MB, 1977, CLIN CHEM, V23, P2207

[2] PH-DEPENDENT DISSOLUTION RATE OF NITROFURANTOIN FROM COMMERCIAL SUSPENSIONS, TABLETS, AND CAPSULES [J].

BATES, TR ;

YOUNG, JM ;

WU, CM ;

ROSENBERG, HA .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (04) :643-645

[3]

BRON J, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1614

[4] NITROFURANTOIN SOLUBILITY IN AQUEOUS UREA SOLUTIONS [J].

CADWALLADER, DE ;

JUN, HW ;

CHEN, LK .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (05) :886-887

[5]

DISANTO AR, 1976, INT J CLIN PHARM BI, V13, P220

[6]

HAILEY FJ, 1967, CURR THER RES CLIN E, V9, P600

[7] NITROFURANTOIN DISPOSITION [J].

HOENER, BA ;

PATTERSON, SE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (06) :808-816

[8] CRYSTALLINE AND MACROCRYSTALLINE NITROFURANTOIN IN TREATMENT OF URINARY-TRACT INFECTION [J].

KALOWSKI, S ;

RADFORD, N ;

KINCAIDS.P .

NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (07) :385-387

[9] ADVERSE REACTIONS TO SULFISOXAZOLE, SULFAMETHOXAZOLE, AND NITROFURANTOIN [J].

KOCHWESER, J ;

SIDEL, VW ;

DEXTER, M ;

PARISH, C ;

FINER, DC ;

KANAREK, P .

ARCHIVES OF INTERNAL MEDICINE, 1971, 128 (03) :399-+

[10] RELATIVE BIOAVAILABILITY OF 4 MACROCRYSTALLINE NITROFURANTOIN CAPSULES [J].

MASON, WD ;

CONKLIN, JD ;

HAILEY, FJ .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 36 (2-3) :105-111

← 1 2 →